Pills. Needles. Dyve. Dyve Bioscience’s mission is to legitimize the skin as a viable 3rd route of drug delivery, providing breakthrough topical therapy where oral or injectable dosage forms are unsuitable due to safety or pharmacokinetic issues. Our paradigm-shifting transdermal platform allows us to formulate a broad range of molecules without compromising pharmacokinetics. For more information, please visit www.dyvebio.com Corporate Contact Jim McGee Dyve Biosciences, Inc. 805-857-6449 jim.mcgee@dyvebio.com Investor Contact Corey Davis LifeSci Advisors, LLC 212-915-2577 cdavis@lifesciadvisors.com
Location: United States, California, Camarillo
Member count: 11-50
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | NaHCO3 | nahco3.com |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 25.06.2021 | Roth Capit... | NEWPORT BEACH, Calif., June 25... | - | - | marketscre... |